RT Journal Article
SR Electronic
T1 Assessment of a new device for delivering aerosol drugs to asthmatic children.
JF Archives of Disease in Childhood
JO Arch Dis Child
FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
SP 787
OP 789
DO 10.1136/adc.56.10.787
VO 56
IS 10
A1 Hodges, I G
A1 Milner, A D
A1 Stokes, G M
YR 1981
UL http://adc.bmj.com/content/56/10/787.abstract
AB A new device, known as the aero-chamber, for delivering aerosol drugs was compared with a standard aerosol inhaler in asthmatic children aged between 5 years 3 months and 13 years 10 months. The study was conducted under double-blind conditions using fenoterol, a beta 2 stimulant, as the active agent and a placebo. Response to treatment was assessed by measuring the peak expiratory flow rate before and after each inhaler. Seven of 10 children had greater mean improvements in peak expiratory flow rates when receiving the active drug from the aerochamber. The aerochamber offers a method for administering a whole range of canistered packaged drugs to children unable to use the standard inhalers.